David Smith
No más puestos en curso
Fortuna: 612 500 $ al 30/04/2024
Perfil
David H.
Smith is the founder and managing director of several Connecticut based Venture Capital firms including Tailwind V.C., LLC (founded in 2000), Contra V.C.
LLC (founded in 1998) and Interim Advantage Fund (founded in 1996).
He is a member of the Board of Directors of Pro-Pharmaceuticals and serves on the Board of Directors of several other companies including Nemogen Inc., Mannix Oil and Spincor, LLC.
He is the co-founder of Canberra Industries, an analytical instrument company and served as Vice President and Director from 1966 - 1986.
In 2000, Merrill Lynch took the company public.
He also founded Canberra Laboratories in 1966, the largest laboratory in New England and served as the CEO until he sold it to MetPath, Inc, a subsidiary of Corning, Inc, in 1986.
He also served as Assistant Secretary at Chemical Bank, NY, from 1961-1966.
He holds a Bachelor of Arts degree from Hamden-Snydey College.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
29/02/2024 | 175 000 ( 12.48% ) | 612 500 $ | 30/04/2024 |
Antiguos cargos conocidos de David Smith.
Empresas | Cargo | Fin |
---|---|---|
GALECTIN THERAPEUTICS INC. | Director/Miembro de la Junta | 12/09/2006 |
INTEGRATE | Director Ejecutivo | - |
Formación de David Smith.
Hampden-Sydney College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
GALECTIN THERAPEUTICS INC. | Health Technology |
INTEGRATE | Health Technology |
- Bolsa de valores
- Insiders
- David Smith